Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression

Josephus P J van Gestel1, Casper W Bollen, Ingeborg van der Tweel

  • 1Department of Pediatrics, the Pediatric Intensive Care Unit, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. j.vangestel@umcutrecht.nl

Critical Care Medicine
|September 4, 2008
PubMed

Insights

Pediatric intensive care unit (ICU) mortality after hematopoietic stem cell transplantation (HSCT) has not clearly decreased. Patient characteristics changed, making survival improvements less evident. Further research is needed to confirm true survival gains.

Area of Science:

  • Pediatric Hematology
  • Critical Care Medicine
  • Transplantation Science

Background:

  • Ongoing debate exists regarding trends in pediatric intensive care unit (ICU) mortality following hematopoietic stem cell transplantation (HSCT).
  • Assessing changes in ICU survival rates over time is crucial for understanding treatment efficacy and patient outcomes.

Purpose of the Study:

  • To analyze intensive care unit (ICU) mortality trends in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT).
  • To identify factors influencing ICU mortality in this vulnerable patient population.

Main Methods:

  • A comprehensive literature search was conducted across MEDLINE, EMBASE, and Cochrane databases, supplemented by manual reference list reviews.
  • Prospective and retrospective cohort studies reporting ICU mortality data for pediatric HSCT patients were included.
  • Meta-regression analysis was employed to assess mortality trends and the impact of prognostic factors over time.

Main Results:

  • Twenty-three studies encompassing 1101 ICU admissions were analyzed, revealing an overall ICU mortality of 60%.
  • Mechanical ventilation, required in 822 patients, was associated with a 71% ICU mortality rate.
  • While univariable analysis suggested a decrease in mortality over time, multivariable analysis indicated that only pulmonary disease remained a significant predictor of mortality, with the association between year of inclusion and mortality being less pronounced.

Conclusions:

  • The widely perceived decrease in pediatric ICU mortality post-HSCT is not clearly supported by current evidence when accounting for changes in patient characteristics.
  • An improvement in ICU survival is less evident after adjusting for factors like pulmonary disease and mechanical ventilation needs.
  • Further research is necessary to definitively confirm any true improvement in ICU survival rates for children after HSCT.
Abstract